Neogen Corp SEC filings NEOG
Neogen Corp has 1,000 filings in SEC EDGAR's recent list, going back to Nov 12, 2013. Its latest annual report, Form ARS, was filed on Aug 21, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 7, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 11-K | Employee savings plan report | Jun 25, 2026 | Dec 31, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 20, 2026 | — |
| 11-K | Employee savings plan report | Jun 24, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2025 | — |
| NT 10-Q | Filing | Jan 10, 2025 | Nov 30, 2024 |
| 11-K | Employee savings plan report | Jun 26, 2024 | Dec 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2024 | — |
| NT 10-K | Filing | Jul 31, 2023 | May 31, 2023 |
| 11-K | Employee savings plan report | Jun 27, 2023 | Dec 31, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2023 | — |
| 425 | Filing | Aug 18, 2022 | — |
| 425 | Filing | Aug 17, 2022 | — |
| 425 | Filing | Aug 12, 2022 | — |
| 425 | Filing | Aug 5, 2022 | — |
| SEC STAFF LETTER | Filing | Aug 4, 2022 | — |
| EFFECT | Filing | Aug 4, 2022 | — |
| CORRESP | Letter to the SEC | Aug 2, 2022 | — |
| CORRESP | Letter to the SEC | Aug 1, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2022 | — |
| PRER14A | Filing | Jul 13, 2022 | — |
| SEC STAFF LETTER | Filing | Jul 11, 2022 | — |
| 425 | Filing | Jul 7, 2022 | — |
| PRER14A | Filing | Jul 1, 2022 | — |
| CORRESP | Letter to the SEC | Jul 1, 2022 | — |
| 11-K | Employee savings plan report | Jun 27, 2022 | Dec 31, 2021 |
| UPLOAD | Letter from the SEC | Jun 24, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2022 | — |
| CORRESP | Letter to the SEC | Jun 9, 2022 | — |
| PRER14A | Filing | Jun 9, 2022 | — |
| CORRESP | Letter to the SEC | Jun 8, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| CORRESP | Letter to the SEC | May 6, 2022 | — |
| PRER14A | Filing | May 6, 2022 | — |
| CORRESP | Letter to the SEC | May 4, 2022 | — |
| 425 | Filing | Apr 21, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2022 | — |
| 425 | Form 425 | Mar 11, 2022 | — |
| 425 | Filing | Dec 15, 2021 | — |
| 425 | Filing | Dec 15, 2021 | — |
| 425 | Filing | Dec 15, 2021 | — |
| 425 | Filing | Dec 14, 2021 | — |
| 425 | Filing | Dec 14, 2021 | — |
| 425 | Filing | Dec 14, 2021 | — |
| 425 | Filing | Dec 14, 2021 | — |
| 11-K | Employee savings plan report | Jun 24, 2021 | Dec 31, 2020 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2021 | — |
| 11-K | Employee savings plan report | Jun 26, 2020 | Dec 31, 2019 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2020 | — |
| 11-K | Employee savings plan report | Jun 28, 2019 | Dec 31, 2018 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2019 | — |
| 11-K | Employee savings plan report | Jun 29, 2018 | Dec 31, 2017 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2018 | — |
| DEFR14A | Filing | Sep 5, 2017 | — |
| 11-K | Employee savings plan report | Jun 27, 2017 | Dec 31, 2016 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2017 | — |
| 11-K | Employee savings plan report | Nov 2, 2016 | Dec 31, 2015 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2016 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2015 | — |
| UPLOAD | Letter from the SEC | May 12, 2015 | — |
| CORRESP | Letter to the SEC | Apr 22, 2015 | — |
| CORRESP | Letter to the SEC | Mar 31, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2015 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 3, 2014 | — |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- NEOG (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- MI
- Headquarters
- Lansing, MI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 711377
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.